Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures
Conditions
Meningioma · Glioblastoma · Acoustic Neuroma · Brain Cancer · Pituitary Adenoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Study leads
Peter Morone, MD
Principal Investigator
Vanderbilt University Medical Center